-+ 0.00%
-+ 0.00%
-+ 0.00%

Hansoh Pharma reports Phase 2 ASCO GU 2026 data for risvutatug rezetecan in mCRPC

路透·02/28/2026 00:03:14

登錄查看新聞詳情